SCHEMBL8763113

SCHEMBL8763113

CC[C@H](NC(=O)C(C)N1CCN(C(=O)CCc2ccccc2)CC(NC(=O)CCc2ccccc2)C1=O)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ XIAP P98170 2/20 0.43
▸ BIRC3 Q13489 2/20 0.43
▸ BIRC2 Q13490 2/20 0.43
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ CCR1 P32246 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ FAAH O00519 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ ACE P12821 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL950189 0.84 CASP1 (0.52) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL12914620 0.84 CASP1 (0.52) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL950190 0.84 CASP1 (0.52) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL12946457 0.84 CASP1 (0.42) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL14370033 0.84 CASP1 (0.52) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL14370030 0.84 HPGD (0.47) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL12914622 0.84 HPGD (0.47) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL12450522 0.83 CASP1 (0.46) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL8763121 0.83 HPGD (0.42) XIAPBIRC3BIRC2HPGDSMN1; SMN2
SCHEMBL13201994 0.78 CTSK (0.43) XIAPBIRC3BIRC2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784628-A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME Vertex Pharmaceuticals Incorporated (US) 1997-07-23 — — EP disclosed
WO-1995035308-A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-12-28 — — WO disclosed
Send feedback